N-Acetylcysteine
SOOCHOW-HY-2017
Phase 3 small_molecule completed
Quick answer
N-Acetylcysteine for Thrombotic Microangiopathies is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Thrombotic Microangiopathies
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed